Mahkam Zanganeh is Co-Chief Executive Officer, President and Director of Summit Therapeutics Inc. (SMMT). The company reported total compensation of $246,047,279 for fiscal year 2025.
| Salary | $616,500 |
|---|---|
| Bonus | $388,395 |
| Stock awards | $0 |
| Option awards | $245,021,384 |
| Non-equity incentive plan | $0 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $21,000 |
| Total | $246,047,279 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Summit Therapeutics Inc. filed April 17, 2026, accession 0001599298-26-000029.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Co-Chief Executive Officer, President and Director | $616,500 | $388,395 | $0 | $245,021,384 | $0 | $0 | $21,000 | $246,047,279 |
| FY2024 | Co-Chief Executive Officer, President and Director | $600,000 | $540,000 | $0 | $0 | $0 | $0 | $21,021 | $1,161,021 |
| FY2023 | Co-Chief Executive Officer, President and Director | $600,000 | $0 | $19,905,115 | $0 | $0 | $0 | $57,809 | $20,562,924 |
Totals as disclosed in each year's own compensation disclosure for Summit Therapeutics Inc..
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Manmeet Soni | Chief Operating Officer, Chief Financial Officer and Director | $249,127,782 |
| Mahkam Zanganeh this page | Co-Chief Executive Officer, President and Director | $246,047,279 |
| Robert Duggan | Co-Chief Executive Officer and Chairman of the Board of Directors | $172,376 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Summit Therapeutics Inc. compensation brief.
Mahkam Zanganeh's compensation sits inside Summit Therapeutics Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.